Tiotropium in Children and Adolescents With Asthma.

CONCLUSION: Once-daily tiotropium as add-on therapy is efficacious and safe in adolescents and children with moderate-to-severe asthma. These results support the expanded indication by regulatory authorities for add-on tiotropium in patients aged ≥6 years. PMID: 31805357 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31805357?dopt=Abstract

Source: Annals of Allergy, Asthma and Immunology - December 1, 2019 Category: Allergy & Immunology Authors: Murphy KR, Chipps BE Tags: Ann Allergy Asthma Immunol Source Type: research